Qiagen NV (QGEN) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

QGEN Qiagen NV

Watchlist

43.750
+0.510+1.18%

Close Nov 27 16:00 ET

43.510
-0.240-0.55%

Pre 04:01 ET

9.72BMarket Cap109.38P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

QIAGEN Strengthens QIAstat-Dx With New Barcelona Site to Drive Growth in Infectious Diseases and Precision Medicine Testing
BusinesswireNov 28 06:00 ET
QIAGEN Launches Novel Tools for Customizing Digital PCR Assays and NGS Panels for Microbial Analysis
GlobeNewswireNov 27 16:05 ET
Qiagen N.V.'s (NYSE:QGEN) Intrinsic Value Is Potentially 43% Above Its Share Price
Simply Wall StNov 25 06:31 ET
Innovations Support QIAGEN Shares Despite Macroeconomic Concerns
Zacks Nov 22 08:35 ET
Morgan Stanley Lists Hedge Funds' Largest Q3 Ownership Increases in Russell 1000 Stocks
Seeking AlphaNov 20 10:13 ET
Syros Pharmaceuticals Gave Notice To Qiagen Manchester Limited Of Its Election To Terminate The Master Collaboration Agreement Dated March 7, 2022
BenzingaNov 18 07:34 ET

Comments

Lnova

Nov 17 15:34

QIAGEN and Bode Technology partner to advance use of GEDmatch PRO forensic genetic genealogy database
Article from late September…
forensic genealogy
$Qiagen NV (QGEN.US)$

Moomoo AI

Jan 8 08:29

Qiagen's high P/E ratio is worrisome due to its poor earnings forecast. Despite the high P/E, investors retain their shares, but this earnings growth rate may eventually impact the share price. The high P/E and future earnings predictions pose a substantial risk to shareholders and potential investors.

There's Reason For Concern Over Qiagen N.V.'s (NYSE:QGEN) Price

Moomoo AI

Dec 24, 2023 06:27

Qiagen's performance is strong due to strategic profit reinvestment, leading to significant earnings growth. Its respectable ROE contributes to a net income increase. Yet, forecasts anticipate a slowdown in future earnings growth.